Top of the page.
Skip the menu to main contents.
Move to main menu.
Skip to main contents.


Main menu starts here.
Skip the main menu to current location in your website.

Current location in your website.
Skip to main contents.


Principle Technology Licensing Agreements

 

1. Licensed-out technologies (overseas)

  Company Country Agreement
2015 TR-Pharm FZ-LLC Turkey Exclusive License agreement for development, manufacture and market of T-614(iguratimod)
2006 Dong-A Pharmaceutical Co., Ltd Korea Patent for T-3811 (Garenoxacin)
2004 Schering-plough Corporation US Patent for T-3811 (Garenoxacin)
2004 Dong-A Pharmaceutical Co., Ltd Korea Patent for TN-3262a (Tosufloxacin tosilate)
2002 Dong-A Pharmaceutical Co., Ltd Korea Patent for T-614 (Iguratimod)
2001 Ferrer Internacional, S.A Spain Patent for T-3912 (Ozenoxacin)
1990 Cyanamid International Corporation Limited Bermuda Patent for Tosufloxacin tosilate
1983 Bristol-Myers Co. US Manufacturing patent for intermediary used in production of cephalosporin
1981 F. Hoffman-La Roche Ltd Swizerland Manufacturing patent for intermediary used in production of cephalosporin
1979 Lederle Piperacillin Inc. US Patent for Piperacillin
1978 Pfizer Inc. US Patent for Cefoperazone

2. Licensed-in technologies (overseas)

  Company Country Agreement
2013 Cempra Inc. US Exclusive License and development agreement
1992 Pfizer Inc. US Patent for Ampiroxicam

3. Cross-Licensing Agreements

  Company Country Agreement
1988 Abbott International Inc. US Cross license for Tosufloxacin tosilate

4. License Agreements (Japan)

  Company In / Out Agreement
2006 Astellas Pharma Out Joint development and Marketing right for T-3811 (Garenoxacin)
2003 Otsuka Pharmaceutical Out Marketing right for TN-3262a (Tosufloxacin tosilate)
2003 Taisho Pharmaceutical Out Marketing right for T-614 (Iguratimod)
2002 Taisho Pharmaceutical Out Marketing right for T-3811 (Garenoxacin)
2002 Novartis Pharma In Marketing right for HALOSPOR
2001 Maruho Out Patent for T-3912 (Ozenoxacin)
1999 Yoshitomi Pharmaceutical Industries In Marketing right for LUPRAC
1998 Eisai Out Patent, Co-development, Co-marketing and bulk supply for T-614 (Iguratimod)
1992 Green Cross Out Co-developmet and co-marketing right for Pazufloxacin mesilate
1991 Taiho Pharmaceutical In Co-development and co-marketing right for YP-14
1988 Abbott Japan Out Patent for Tosufloxacin tosilate

Footer starts here.

Pages ends here.
Move to top of the page.